A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

NCT05093933 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6106

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Heart Failure With Reduced Ejection Fraction

Interventions

DRUG: Vericiguat
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC